Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Grace Wang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Sleep Medicine|April 6, 2010
Xyrem (sodium oxybate) postmarketing adverse event reporting systemY Grace Wang
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|December 9, 2009
Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversionY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Sodium oxybate: updates and correction to previously published safety dataY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Sleep Medicine|April 4, 2017
Assessing sleepiness and cataplexy in children and adolescents with narcolepsy: a review of current patient-reported measuresKhadra Benmedjahed, Y Grace Wang, Jérémy Lambert, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trialMichael Spaeth, Robert M Bennett, Beverly A Benson, et al.
Nature and Science of Sleep|September 2, 2017
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHADY Grace Wang, Khadra Benmedjahed, Jérémy Lambert, et al.
Journal of Psychopharmacology (Oxford, England)|October 2, 2018
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitorLawrence P Carter, Jack E Henningfield, Y Grace Wang, et al.
Sleep Medicine|December 17, 2021
Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 yearsY Grace Wang, Diane Menno, Abby Chen, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|November 9, 2023
Effect of sodium oxybate on body mass index in pediatric patients with narcolepsyYves Dauvilliers, Gert Jan Lammers, Michel Lecendreux, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 11, 2022
Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patientsMichel Lecendreux, Giuseppe Plazzi, Yves Dauvilliers, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Sleep Medicine|April 6, 2010
Xyrem (sodium oxybate) postmarketing adverse event reporting systemY Grace Wang
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|December 9, 2009
Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversionY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Sodium oxybate: updates and correction to previously published safety dataY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Sleep Medicine|April 4, 2017
Assessing sleepiness and cataplexy in children and adolescents with narcolepsy: a review of current patient-reported measuresKhadra Benmedjahed, Y Grace Wang, Jérémy Lambert, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trialMichael Spaeth, Robert M Bennett, Beverly A Benson, et al.
Nature and Science of Sleep|September 2, 2017
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHADY Grace Wang, Khadra Benmedjahed, Jérémy Lambert, et al.
Journal of Psychopharmacology (Oxford, England)|October 2, 2018
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitorLawrence P Carter, Jack E Henningfield, Y Grace Wang, et al.
Sleep Medicine|December 17, 2021
Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 yearsY Grace Wang, Diane Menno, Abby Chen, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|November 9, 2023
Effect of sodium oxybate on body mass index in pediatric patients with narcolepsyYves Dauvilliers, Gert Jan Lammers, Michel Lecendreux, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 11, 2022
Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patientsMichel Lecendreux, Giuseppe Plazzi, Yves Dauvilliers, et al.
Pageof 1